{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T13:47:27Z","timestamp":1724680047994},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,8]]},"DOI":"10.7759\/cureus.18599","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T06:36:11Z","timestamp":1633847771000},"source":"Crossref","is-referenced-by-count":3,"title":["Fixed Drug Eruption Secondary to Four Anti-diabetic Medications: An Unusual Case of Polysensitivity"],"prefix":"10.7759","author":[{"given":"Dana","family":"Al Masri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Fleifel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Hirbli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-7-S1-S10","article-title":"Drug allergy","volume":"7","author":"Warrington R","year":"2011","unstructured":"Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin Immunol. 2011, 7:S10. 10.1186\/1710-1492-7-S1-S10","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02853.x","article-title":"Fixed drug eruption (FDE): changing scenario of incriminating drugs","volume":"45","author":"Sehgal VN","year":"2006","unstructured":"Sehgal VN, Srivastava G. Fixed drug eruption (FDE): changing scenario of incriminating drugs. Int J Dermatol. 2006, 45:897-908. 10.1111\/j.1365-4632.2006.02853.x","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_481_17","article-title":"Fixed-drug eruptions: what can we learn from a case series?","volume":"63","author":"Jhaj R","year":"2018","unstructured":"Jhaj R, Chaudhary D, Asati D, Sadasivam B. Fixed-drug eruptions: what can we learn from a case series?. Indian J Dermatol. 2018, 63:332-7. 10.4103\/ijd.IJD_481_17","journal-title":"Indian J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650400102024","article-title":"Fixed drug eruption. A brief review","volume":"120","author":"Korkij W","year":"1984","unstructured":"Korkij W, Soltani K. Fixed drug eruption. A brief review. Arch Dermatol. 1984, 120:520-4. 10.1001\/archderm.1984.01650400102024","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13149-012-0237-x","article-title":"Fixed drug eruption in dermatology setting in Lom\u00e9 (Togo): a retrospective study of 321 cases [Article in French]","volume":"105","author":"Saka B","year":"2012","unstructured":"Saka B, Kombat\u00e9 K, M\u00e9dougou BH, et al.. Fixed drug eruption in dermatology setting in Lom\u00e9 (Togo): a retrospective study of 321 cases [Article in French]. Bull Soc Pathol Exot. 2012, 105:384-7. 10.1007\/s13149-012-0237-x","journal-title":"Bull Soc Pathol Exot"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/236703","article-title":"Clinical features and drug characteristics of patients with generalized fixed drug eruption in the west of Iran (2005-2014)","volume":"2015","author":"Kavoussi H","year":"2015","unstructured":"Kavoussi H, Rezaei M, Derakhshandeh K, Moradi A, Ebrahimi A, Rashidian H, Kavoussi R. Clinical features and drug characteristics of patients with generalized fixed drug eruption in the west of Iran (2005-2014). Dermatol Res Pract. 2015, 2015:236703. 10.1155\/2015\/236703","journal-title":"Dermatol Res Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2012.02.002","article-title":"Fixed-drug eruption: a retrospective study in a single referral center in northern Taiwan","volume":"30","author":"Lee CH","year":"2012","unstructured":"Lee CH, Chen YC, Cho YT, Chang CY, Chu CY. Fixed-drug eruption: a retrospective study in a single referral center in northern Taiwan. Dermatologica Sin. 2012, 30:11-5. 10.1016\/j.dsi.2012.02.002","journal-title":"Dermatologica Sin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2010.0980","article-title":"A three-year-analysis of fixed drug eruptions in hospital settings in France","volume":"20","author":"Brahimi N","year":"2010","unstructured":"Brahimi N, Routier E, Raison-Peyron N, et al.. A three-year-analysis of fixed drug eruptions in hospital settings in France. Eur J Dermatol. 2010, 20:461-4. 10.1684\/ejd.2010.0980","journal-title":"Eur J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00451.x","article-title":"Drugs causing fixed eruptions: a study of 450 cases","volume":"37","author":"Mahboob A","year":"1998","unstructured":"Mahboob A, Haroon TS. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol. 1998, 37:833-8. 10.1046\/j.1365-4362.1998.00451.x","journal-title":"Int J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(94)70007-9","article-title":"Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22","volume":"30","author":"Pellicano R","year":"1994","unstructured":"Pellicano R, Ciavarella G, Lomuto M, Di Giorgio G. Genetic susceptibility to fixed drug eruption: evidence for a link with HLA-B22. J Am Acad Dermatol. 1994, 30:52-4. 10.1016\/s0190-9622(94)70007-9","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117854","article-title":"Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype","volume":"45","author":"Ozkaya-Bayazit E","year":"2001","unstructured":"Ozkaya-Bayazit E, Akar U. Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype. J Am Acad Dermatol. 2001, 45:712-7. 10.1067\/mjd.2001.117854","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e32832cda4c","article-title":"Fixed drug eruption: pathogenesis and diagnostic tests","volume":"9","author":"Shiohara T","year":"2009","unstructured":"Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009, 9:316-21. 10.1097\/ACI.0b013e32832cda4c","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref13","article-title":"Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole","volume":"16","author":"Ozkaya E","year":"2006","unstructured":"Ozkaya E. Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole. Eur J Dermatol. 2006, 16:591-2.","journal-title":"Eur J Dermatol"},{"key":"ref14","article-title":"Magnesium stearate: an underestimated allergen","volume":"26","author":"Tammaro A","year":"2012","unstructured":"Tammaro A, Abruzzese C, Narcisi A, Cortesi G, Persechino F, Parisella FR, Persechino S. Magnesium stearate: an underestimated allergen. J Biol Regul Homeost Agents. 2012, 26:783-4.","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5195\/ijms.2020.646","article-title":"Fixed drug eruption: a rare case of polysensitivity between two unrelated fixed dose combination preparations - a case report","volume":"8","author":"Kaushal J","year":"2020","unstructured":"Kaushal J, Rakesh A. Fixed drug eruption: a rare case of polysensitivity between two unrelated fixed dose combination preparations - a case report. International Journal of Medical Students. 2020, 8:291-4. 10.5195\/ijms.2020.646","journal-title":"International Journal of Medical Students"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/srep40373","article-title":"Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon","volume":"7","author":"Bettini S","year":"2017","unstructured":"Bettini S, Boutet-Robinet E, Cartier C, et al.. Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon. Sci Rep. 2017, 7:40373. 10.1038\/srep40373","journal-title":"Sci Rep"},{"key":"ref17","article-title":"Fixed drug eruption due to doxycycline and metronidazole","volume":"69","author":"Walfish AE","year":"2002","unstructured":"Walfish AE, Sapadin AN. Fixed drug eruption due to doxycycline and metronidazole. Cutis. 2002, 69:207-8.","journal-title":"Cutis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-015-0145-2","article-title":"Fixed drug eruption to sitagliptin","volume":"14","author":"Gupta M","year":"2015","unstructured":"Gupta M, Gupta A. Fixed drug eruption to sitagliptin. J Diabetes Metab Disord. 2015, 14:18. 10.1186\/s40200-015-0145-2","journal-title":"J Diabetes Metab Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.25179\/tjem.2018-63449","article-title":"Case report: fixed drug eruption caused by dapagliflozin","volume":"23","author":"Keskin M","year":"2019","unstructured":"Keskin M, Tekin \u00d6, Koca A, Da\u011fdeviren M, \u015eim\u015fek G, Altay M, Ertu\u011frul D. Case report: fixed drug eruption caused by dapagliflozin. Turk J Endocrinol Metab. 2019, 23:64-7. 10.25179\/tjem.2018-63449","journal-title":"Turk J Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/01720610-201010000-00003","article-title":"What are these lesions that spread from the lips. Fixed drug eruption","volume":"23","author":"Monroe JR","year":"2010","unstructured":"Monroe JR. What are these lesions that spread from the lips. Fixed drug eruption. JAAPA. 2010, 23:14. 10.1097\/01720610-201010000-00003","journal-title":"JAAPA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64942-fixed-drug-eruption-secondary-to-four-anti-diabetic-medications-an-unusual-case-of-polysensitivity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:46Z","timestamp":1707507046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64942-fixed-drug-eruption-secondary-to-four-anti-diabetic-medications-an-unusual-case-of-polysensitivity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.18599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,8]]}}}